Selma Ugurel Selected Research

Selma Ugurel Research Topics

Disease

107	Melanoma (Melanoma, Malignant) 03/2024 - 08/2002
74	Neoplasms (Cancer) 05/2024 - 01/2003
22	Skin Neoplasms (Skin Cancer) 12/2023 - 03/2007
20	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2003
20	Merkel Cell Carcinoma 12/2023 - 05/2006
9	Disease Progression 01/2023 - 08/2002
6	Brain Neoplasms (Brain Tumor) 01/2023 - 09/2008
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2022 - 03/2007
4	Uveal melanoma 10/2023 - 06/2003
3	Carcinoma (Carcinomatosis) 05/2024 - 11/2020
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 07/2006
3	Dermatofibrosarcoma 01/2017 - 03/2007
2	COVID-19 01/2023 - 01/2022
2	Glioma (Gliomas) 12/2022 - 11/2022
2	Encephalitis (Encephalitis, Rasmussen) 12/2022 - 11/2022
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2020
2	Myasthenia Gravis 03/2021 - 01/2019
2	Inflammation (Inflammations) 01/2021 - 01/2021
2	Fibrosis (Cirrhosis) 01/2021 - 01/2014
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2014 - 07/2010
1	Carcinogenesis 04/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023
1	Lymphadenopathy 05/2023
1	Lymphatic Metastasis 05/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023
1	Leukocytosis (Pleocytosis) 11/2022
1	Nevus (Nevi) 11/2022
1	Necrosis 01/2022
1	Cardiotoxicity 01/2022
1	Cytokine Release Syndrome 10/2021

Drug/Important Bio-Agent (IBA)

51	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2016
22	Biomarkers (Surrogate Marker)IBA 10/2023 - 08/2002
17	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2024 - 02/2007
17	NivolumabIBA 12/2023 - 01/2016
16	IpilimumabIBA 12/2023 - 11/2016
12	pembrolizumabIBA 04/2022 - 01/2016
10	Phosphotransferases (Kinase)IBA 01/2023 - 08/2004
10	AntibodiesIBA 11/2022 - 05/2008
8	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 07/2005
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2005
6	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 03/2007
5	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2017
5	Adenosine Triphosphate (ATP)IBA 09/2017 - 01/2003
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 01/2021
4	VemurafenibIBA 01/2021 - 01/2014
4	ParaffinIBA 07/2017 - 04/2007
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2023 - 01/2017
3	cyclopropapyrroloindoleIBA 01/2023 - 01/2021
3	Messenger RNA (mRNA)IBA 11/2022 - 01/2014
3	avelumabIBA 11/2022 - 07/2021
3	AntigensIBA 06/2021 - 06/2004
3	Monoclonal AntibodiesIBA 01/2020 - 07/2016
3	InterferonsIBA 01/2020 - 09/2008
3	Dacarbazine (DIC)FDA LinkGeneric 09/2017 - 09/2008
3	Formaldehyde (Formol)FDA Link 07/2017 - 01/2014
3	Histocompatibility Antigens Class IIBA 01/2017 - 06/2004
3	Indicators and Reagents (Reagents)IBA 08/2009 - 08/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2021
2	Interleukin-17 (Interleukin 17)IBA 09/2023 - 01/2023
2	VaccinesIBA 05/2023 - 11/2012
2	InterleukinsIBA 01/2023 - 01/2023
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 03/2006
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2022
2	Leucine (L-Leucine)FDA Link 12/2022 - 11/2022
2	trametinibIBA 01/2022 - 01/2018
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2020 - 01/2020
2	Histone Deacetylases (Histone Deacetylase)IBA 06/2019 - 02/2006
2	dabrafenibIBA 01/2018 - 01/2014
2	denileukin diftitox (Ontak)FDA Link 01/2014 - 07/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2013 - 03/2012
2	LigandsIBA 02/2013 - 08/2009
2	Peptides (Polypeptides)IBA 11/2012 - 06/2007
2	Tumor Biomarkers (Tumor Markers)IBA 07/2009 - 12/2005
2	Drug CombinationsIBA 09/2006 - 06/2003
2	HLA-DR Antigens (HLA-DR)IBA 06/2004 - 08/2002
1	Viral ProteinsIBA 04/2024
1	COVID-19 VaccinesIBA 05/2023
1	Dimethyl FumarateIBA 01/2023
1	Monomeric GTP-Binding ProteinsIBA 01/2023
1	CytokinesIBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	apremilastIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 11/2022
1	S 27IBA 08/2022
1	Peptide Receptors (Peptide Receptor)IBA 03/2022
1	Radioisotopes (Radionuclides)IBA 03/2022
1	Deoxyglucose (2 Deoxy D glucose)IBA 02/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	encorafenibIBA 10/2021
1	binimetinibIBA 10/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2021
1	TransferasesIBA 10/2021

Therapy/Procedure

84	Therapeutics 05/2024 - 08/2002
20	Immunotherapy 04/2024 - 05/2008
13	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
7	Radiotherapy 03/2022 - 04/2007
5	Aftercare (After-Treatment) 05/2024 - 04/2007
2	Combination Drug Therapy (Combination Chemotherapy) 09/2017 - 04/2007
2	Palliative Care (Palliative Therapy) 06/2008 - 01/2007
1	Immunomodulation 01/2023